Synopsis
This biographical novel portrays the professional and personal lives of neuroscientists David Joule and Marie Wilson. The narrative traces the development of their relationship and the achievement of their scientific goals. Everything happens within the context of a “feel good” love story. Along the way, there are real life descriptions of how science is conducted, a strong case is made for understanding why drug addiction is a chronic brain disease, and the mechanism underlying the discovery of a novel treatment for addictive disorders is explained. Although the story is fictional, much of the science is true, particularly as it pertains to addiction. The storyline embodies the message that people suffering from addiction need to be treated and need to be treated well, without the stigma and shame that is still prevalent today. Next to Last Chapter is both entertaining and informative. Much of the information is based on the author’s personal experience in neuroscience and addiction medicine. Some of the life experiences described resemble real events. Descriptions of the scientific process and of academic life are mostly true. Many will find the love story endearing if not too good to be true. Perhaps in different ways, Next to Last Chapter will be interesting and enjoyable to both scientists and non-scientists.
About the Author
Stanley D. Glick, Ph.D., M.D. (Albert Einstein College of Medicine, 1969, 1971) From 2000 until his retirement in June of 2014, Dr. Glick was the Director of the Center for Neuropharmacology and Neuroscience at Albany Medical College. Before then he was Chair of the Department of Pharmacology and Neuroscience (1995-2000) and Chair of the Department of Pharmacolgoy and Toxicology (1984-95). Dr. Glick personally trained nineteen Ph.D. students, six M.S. students and ten postdoctoral fellows as well as numerous medical students. Prior to joining Albany Medical College, Dr. Glick was a professor of pharmacology at Mount Sinai School of Medicine (1971-1984). Dr. Glick's major research interest focuses on the neurobiology of drug addiction. His research was funded by the National Institute on Drug Abuse from 1972-2012. Dr. Glick is a co-inventor of a novel group of agents for treating drug addiction. 18-methoxycoronaridine (18-MC), the lead agent of this group of compounds, is likely to be useful in treating multiple forms of drug abuse, including opioid and stimulant dependence, alcoholism and smoking. Other studies indicate that it may also be useful in treating obesity. Dr. Glick performed a variety of administrative and service functions for the Albany Medical College and the Albany Medical Center. He served on numerous governance committees, the human subjects research committee, many graduate program committees, the student promotions committee, and strategic planning steering committees. For four years (1993-97), Dr. Glick was a member of the Board of Directors of the medical center. From 2000-2013, he was chair of the Scientific Advisory Board, which advised the dean on all matters related to research. Dr. Glick has authored or co-authored over 480 experimental papers, reviews and abstracts. He has served as editor of a scientific journal and of a professional newsletter, in addition to serving on editorial boards and National Institutes of Health advisory committees. Dr. Glick's first novel, N Equals One, was published in October of 2014.
"About this title" may belong to another edition of this title.
